Cargando…
Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease
BACKGROUND: Molecular profiling has identified at least four subtypes of invasive breast carcinoma, which exhibit distinct clinical behaviour. There is good evidence now that DCIS represents the non-obligate precursor to invasive breast cancer and therefore it should be possible to identify similar...
Autores principales: | Clark, S E, Warwick, J, Carpenter, R, Bowen, R L, Duffy, S W, Jones, J L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3039794/ https://www.ncbi.nlm.nih.gov/pubmed/21139586 http://dx.doi.org/10.1038/sj.bjc.6606021 |
Ejemplares similares
-
A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial
por: Pinder, S E, et al.
Publicado: (2010) -
Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence
por: Barnes, N, et al.
Publicado: (2006) -
Tumour biomarker expression relative to age and molecular subtypes of invasive breast cancer
por: Morrison, D H, et al.
Publicado: (2012) -
Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma
por: Engels, C C, et al.
Publicado: (2014) -
Clinical significance of CD151 overexpression in subtypes of invasive breast cancer
por: Kwon, M J, et al.
Publicado: (2012)